GlassScriptPhysician profile
Tuesday E Pearson
NPI 1043650682
$1,089.05
in general payments reported to CMS, 2019-2025
12 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $131 · 2021: $282 · 2022: $102 · 2023: $61.39 · 2024: $103 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $345.54 | 2019-2023 | |
| Hologic Sales and Service, LLC | $185.34 | 2022-2025 | Aptima |
| Myovant Sciences INC. | $177.59 | 2021 | |
| Astellas Pharma US INC | $103.47 | 2024 | Veozah |
| Exact Sciences Corporation | $93.02 | 2025 | The Cologuard Plus Collection Kit |
| Mayne Pharma Commercial LLC | $56.82 | 2025 | |
| Merck Sharp & Dohme LLC | $31.01 | 2019-2020 | |
| Myriad Women'S Health, INC. | $29.16 | 2023 | Myrisk |
| Therapeuticsmd, INC. | $20.81 | 2021 | |
| Allergan, INC. | $18.32 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.94 | 2019 | |
| Agile Therapeutics, INC. | $13.03 | 2023 | Twirla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tuesday Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.